These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

98 related items for PubMed ID: 7824763

  • 1. A fixed-dose study of adinazolam-SR tablets in generalized anxiety disorder.
    Wilcox CS, Ryan PJ, Morrissey JL, Cohn JB, DeFrancisco DF, Linden RD, Heiser JF.
    Prog Neuropsychopharmacol Biol Psychiatry; 1994 Oct; 18(6):979-93. PubMed ID: 7824763
    [Abstract] [Full Text] [Related]

  • 2. Adinazolam-SR in panic disorder with agoraphobia: relationship of daily dose to efficacy.
    Carter CS, Fawcett J, Hertzman M, Papp LA, Jones W, Patterson WM, Swinson RP, Weise CC, Maddock RJ, Denahan AQ.
    J Clin Psychiatry; 1995 May; 56(5):202-10. PubMed ID: 7737960
    [Abstract] [Full Text] [Related]

  • 3. Double-blind efficacy and safety study comparing adinazolam mesylate and placebo in depressed inpatients.
    Smith WT, Glaudin V.
    Acta Psychiatr Scand; 1986 Sep; 74(3):238-45. PubMed ID: 3538786
    [Abstract] [Full Text] [Related]

  • 4. A comparison of adinazolam and desipramine in the treatment of major depression.
    Kennedy SH, de Groot J, Ralevski E, Reed K.
    Int Clin Psychopharmacol; 1991 Sep; 6(2):65-76. PubMed ID: 1960382
    [Abstract] [Full Text] [Related]

  • 5. Adinazolam--a new antidepressant: findings of a placebo-controlled, double-blind study in outpatients with major depression.
    Dunner D, Myers J, Khan A, Avery D, Ishiki D, Pyke R.
    J Clin Psychopharmacol; 1987 Jun; 7(3):170-2. PubMed ID: 3298327
    [Abstract] [Full Text] [Related]

  • 6. Comparison of adinazolam, amitriptyline, and diazepam in endogenous depressive inpatients exhibiting DST nonsuppression or abnormal contingent negative variation.
    Ansseau M, Devoitille JM, Papart P, Vanbrabant E, Mantanus H, Timsit-Berthier M.
    J Clin Psychopharmacol; 1991 Jun; 11(3):160-5. PubMed ID: 2066454
    [Abstract] [Full Text] [Related]

  • 7. Gepirone extended-release treatment of anxious depression: evidence from a retrospective subgroup analysis in patients with major depressive disorder.
    Alpert JE, Franznick DA, Hollander SB, Fava M.
    J Clin Psychiatry; 2004 Aug; 65(8):1069-75. PubMed ID: 15323591
    [Abstract] [Full Text] [Related]

  • 8. Adinazolam sustained-release treatment of panic disorder: a double-blind study.
    Davidson JR, Beitman B, Greist JH, Maddock RJ, Lewis CP, Sheridan AQ, Carter C, Krishnan KR, Liebowitz MR, Haack DG.
    J Clin Psychopharmacol; 1994 Aug; 14(4):255-63. PubMed ID: 7962681
    [Abstract] [Full Text] [Related]

  • 9. Adinazolam, a new triazolobenzodiazepine, and imipramine in the treatment of major depressive disorder.
    Amsterdam JD, Kaplan M, Potter L, Bloom L, Rickels K.
    Psychopharmacology (Berl); 1986 Aug; 88(4):484-8. PubMed ID: 3085137
    [Abstract] [Full Text] [Related]

  • 10. Adinazolam, diazepam, imipramine, and placebo in major depressive disorder: a controlled study.
    Rickels K, London J, Fox I, Hassman H, Csanalosi I, Weise C.
    Pharmacopsychiatry; 1991 Jul; 24(4):127-31. PubMed ID: 1754608
    [Abstract] [Full Text] [Related]

  • 11. Deramciclane in the treatment of generalized anxiety disorder: a placebo-controlled, double-blind, dose-finding study.
    Naukkarinen H, Raassina R, Penttinen J, Ahokas A, Jokinen R, Koponen H, Lepola U, Kanerva H, Lehtonen L, Pohjalainen T, Partanen A, Mäki-Ikola O, Rouru J, Deramciclane Dose-Finding Study Group.
    Eur Neuropsychopharmacol; 2005 Dec; 15(6):617-23. PubMed ID: 15949921
    [Abstract] [Full Text] [Related]

  • 12. Adinazolam mesylate and placebo in depressed outpatients: a 6-week, double-blind comparison.
    Cohn JB, Pyke RE, Wilcox CS.
    J Clin Psychiatry; 1988 Apr; 49(4):142-7. PubMed ID: 3281930
    [Abstract] [Full Text] [Related]

  • 13. Comparison of adinazolam, amitriptyline, and placebo in the treatment of melancholic depression.
    Hicks F, Robins E, Murphy GE.
    Psychiatry Res; 1988 Feb; 23(2):221-7. PubMed ID: 3283804
    [Abstract] [Full Text] [Related]

  • 14. Efficacy of once-daily extended release quetiapine fumarate in patients with different levels of severity of generalized anxiety disorder.
    Montgomery SA, Locklear JC, Svedsäter H, Eriksson H.
    Int Clin Psychopharmacol; 2014 Sep; 29(5):252-62. PubMed ID: 24394383
    [Abstract] [Full Text] [Related]

  • 15. A controlled trial of adinazolam versus desipramine in geriatric depression.
    Feighner JP, Boyer WF, Hendrickson GG, Pambakian RA, Doroski VS.
    Int Clin Psychopharmacol; 1990 Jul; 5(3):227-32. PubMed ID: 2230067
    [Abstract] [Full Text] [Related]

  • 16. Double-blind comparison of alprazolam and adinazolam for panic and phobic disorders.
    Pyke RE, Greenberg HS.
    J Clin Psychopharmacol; 1989 Feb; 9(1):15-21. PubMed ID: 2651489
    [Abstract] [Full Text] [Related]

  • 17. An evaluation of the anxiolytic SC 48,274 in generalized anxiety disorder (GAD).
    Cutler NR, Sramek JJ, Macpherson AE, Doss MG, Benes CO, Howard SF.
    Prog Neuropsychopharmacol Biol Psychiatry; 1994 Jul; 18(4):685-94. PubMed ID: 7938559
    [Abstract] [Full Text] [Related]

  • 18. Efficacy and safety of hydroxyzine in the treatment of generalized anxiety disorder: a 3-month double-blind study.
    Llorca PM, Spadone C, Sol O, Danniau A, Bougerol T, Corruble E, Faruch M, Macher JP, Sermet E, Servant D.
    J Clin Psychiatry; 2002 Nov; 63(11):1020-7. PubMed ID: 12444816
    [Abstract] [Full Text] [Related]

  • 19. Psychomotor and memory effects of two adinazolam formulations assessed by a computerized neuropsychological test battery.
    Fleishaker JC, Sisson TA, Sramek JJ, Conrad J, Veroff AE, Cutler NR.
    J Clin Pharmacol; 1993 May; 33(5):463-9. PubMed ID: 8331205
    [Abstract] [Full Text] [Related]

  • 20. Efficacy of venlafaxine extended-release capsules in nondepressed outpatients with generalized anxiety disorder: A 6-month randomized controlled trial.
    Gelenberg AJ, Lydiard RB, Rudolph RL, Aguiar L, Haskins JT, Salinas E.
    JAMA; 2000 Jun 21; 283(23):3082-8. PubMed ID: 10865302
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.